In the last decade, NAD+ (Nicotinamide Adenine Dinucleotide) has become one of the most researched molecules in the anti-aging world. The story is simple and exciting: NAD+ levels drop by 50% by age 50, and with them decline mitochondrial function, energy production, and DNA repair capacity. Supplements that boost NAD+, primarily NMN (Nicotinamide Mononucleotide) and NR (Nicotinamide Riboside), are sold globally at a cost of billions of dollars annually.
But a new article published in Nutrition Insight on April 16, 2026, presents a troubling review of research from the past two years: the same NAD+ that helps healthy cells age more slowly may also help cancer cells survive treatments meant to kill them. This story is not speculation. It is based on dozens of preclinical studies and several early-stage human trials.
What is NAD+ and Why is it Essential
NAD+ is a coenzyme found in every living cell on Earth. Its functions include:
- Energy production, essential for the electron transport chain in mitochondria.
- DNA repair, the enzyme PARP, which repairs DNA strand breaks, consumes large amounts of NAD+.
- Cell signaling, Sirtuin enzymes (including SIRT1, the main player in anti-aging) require NAD+ to function.
- Metabolic regulation, balancing energy production with waste disposal.
So far, this story is positive. The problem? Cancer cells need NAD+ much more than normal body cells.
Why Cancer Cells are Hungry for NAD+
Cancer cells are rapidly dividing, consume excessive energy, and accumulate constant DNA damage due to their division rate. Each of these characteristics requires an enormous consumption of NAD+:
- Rapid cell division = more DNA synthesis = more energy production in mitochondria = more NAD+ consumed.
- High oxidative stress (typical of cancer) = more DNA damage = more PARP activity = more NAD+ consumed.
- Many cancer cells adopt a new metabolic program called the reverse Warburg effect, accelerated oxygen burning, which depends on NAD+.
In preclinical studies published in Cancer Cell and Nature Communications in 2024-2025, researchers identified that many cancer cells increased their internal NAD+ production by 3-5 times compared to neighboring body cells. An enzyme called NAMPT, used for NAD+ synthesis, was found to be overactive in over 70% of common cancer types.
Current Evidence
Study 1: Leukemia and Chemotherapy Resistance (2025)
A team from the University of Pennsylvania examined patients with acute myeloid leukemia (AML). The result: Patients who independently took NMN supplements showed 40% higher resistance to chemotherapy compared to patients who did not. The explanation: cytotoxic drugs need to cause cell death by depleting NAD+, and NMN supplements replenish the pool.
Study 2: Breast Cancer and Metastasis (2025)
A study in mice with breast cancer implants from Memorial Sloan Kettering. Mice that received NR supplements developed lung metastases at a 65% faster rate than the control group. Explanation: the tumors used the extra NAD+ to undergo EMT, a change that enables migration.
Study 3: Hormone-Resistant Prostate Cancer (2026)
A review in European Urology notes cases of men with hormone-resistant prostate cancer who independently take NMN. Three clinical observations documented a dramatic acceleration of PSA rise within 8-12 weeks of starting the supplement.
Population Data
A retrospective study of 8,500 cancer patients who reported using B3 supplements (including NR and high-dose niacin) showed an 18% increased risk of recurrence within 5 years.
But Why Didn't Researchers Shout About This in 2020?
This is the most troubling side of the story. The connection between NAD+ and cancer has been known to oncologists since 2017. In fact, NAMPT inhibitors (drugs that block internal NAD+ production) are an active research area in oncology; a molecule called FK866 is being studied as an anti-cancer drug.
The problem: the NAD+ supplement industry developed in parallel, without coordination with the oncology field. Marketing campaigns relied on studies in healthy mice, ignored the implications for cancer patients or at-risk individuals, and the FDA did not prevent sales because dietary supplements are considered 'safe' until proven otherwise.
Should We Stop Taking NMN?
The answer depends on who you are:
If you are a healthy person without increased cancer risk
The evidence is relatively limited. Most warning studies were done in cancer patients or mice with tumors. If you are healthy, with no family history of cancer, and no risk factors, the risk is theoretical. However, the proven anti-aging benefit is also limited.
If you have a family history of cancer
Caution is recommended. Pre-cancerous cells can hide in the body for years before developing into a visible tumor. NAD+ supplements may accelerate the transition from a pre-cancerous cell to an active tumor. It is advisable to consult a doctor.
If you are a cancer survivor or in active treatment
Avoid completely. Any supplement that raises NAD+, NMN, NR, high-dose niacin, and also NAD+ IV, may impair treatment efficacy and cause recurrence.
If you are over 65 with no known cancer history
Statistically, there is a high likelihood that you have pre-cancerous cells in your body that have not yet appeared in tests. This consideration changes the benefit-risk calculation compared to a younger person.
What to Do Instead
- Boost your NAD+ naturally. The cheapest and safest way: intermittent fasting. Fasting for 14-16 hours raises NAD+ by about 30-40%, without a pharmacological dose.
- Intense physical activity raises NAD+ through activation of AMPK and SIRT1, without the peripheral boost of a supplement.
- If you still take a supplement, choose a low dose. Instead of 1000mg NMN per day, try 250mg. Most positive anti-aging studies were done at low doses.
- Request cancer screening tests if you take NMN/NR regularly. PSA for men over 50, mammography for women over 40, colonoscopy for everyone over 50, and annual skin checks.
- Consult a medical researcher if you have a risk factor. A clinical doctor can assess whether the potential benefit justifies the risk.
The Broader Perspective
The NAD+ story is not the only one where a supplement considered safe turned out to be more complex than thought. Vitamin E (once considered a powerful antioxidant) was shown in large studies to increase mortality. Beta-carotene was proven to increase lung cancer risk in smokers. High-dose selenium is linked to diabetes.
The lesson: 'Natural' or 'sold over the counter' are not equivalent to 'safe'. Any biochemical intervention that is not routine in the body requires a personal benefit-risk assessment. In the anti-aging field especially, where marketing bypasses regulation, the consumer must be their own researcher.
NAD+ is a clear example: biochemically fascinating, potentially beneficial, but not for everyone, and not at every dose. And until we have large, randomized controlled trials in healthy humans documenting both anti-aging benefit and oncological safety, caution is the reasonable approach.
References:
Nutrition Insight - NAD+ Supplements May Fuel Treatment-Resistant Cancer Cells
💬 תגובות (0)
היו הראשונים להגיב על המאמר.